Cataract

A 56-year-old woman presented to the ophthalmology office at the Lahey Clinic with 1 week of left eye pain associated with burning, injection and a left-sided headache without any vision changes.

Bausch + Lomb’s ClearVisc dispersive ophthalmic viscosurgical device has received FDA approval for use in ophthalmic surgery, according to a press release.

If glaucoma is diagnosed early, treatment for the disease can be delayed, as the treatment effect is usually modest and the patient has time to be treated at a later point.

Properly educating cataract patients is essential for informed consent and helps them to be more involved in their care. When they understand how cataracts are treated and are aware of their options, they have a more satisfying experience.

Cataract Surgery: Telling It Like It Is 2021 has been rescheduled for June 9 to 13, 2021, at the Omni Amelia Island Resort in Fernandina Beach, Florida.

IOL scaffold helps the surgeon not only in cases of posterior capsule rupture but also in preventing posterior capsule rupture in Morgagnian cataracts.

LensGen has closed on $10 million to help fund the Juvene IOL pivotal FDA study, according to a press release.

The SARS-CoV-2 pandemic has forced ophthalmologists to embrace new technologies and approach patient care differently, Ike K. Ahmed, MD, FRCSC, said at Octane’s virtual Ophthalmology Technology Summit.

A novel drive-through IOP monitoring clinic in Raleigh, North Carolina, allows patients with moderate to severe glaucoma to be examined by an ophthalmologist so their disease can be monitored with minimal exposure during the COVID-19 pandemic.

Social distancing, reducing our clinical volume and canceling elective surgeries have led nationally and in Ohio to a significant flattening of our curve. Locally we are currently trending at a model of social distancing between 60% and 80% and have blunted the curve such that our health care organization can now get back to elective patients while not being overwhelmed with COVID-19 inpatients.